imaginostics

Transforming patient care through precision medicine

MISSION

To empower clinicians by pushing the frontiers of quantitative imaging for precision medicine.


Biomarker Solutions for:

  • Full body quantitative vascular imaging (safe for renal patients)
  • Neurologic disease
  • Neurofunctional pharmacokinetics
  • Cardiac
  • Kidney
  • Cancer

Imaginostics has a special interest in Alzheimer’s Disease and Related Dementia (ADRD). We believe our biomarkers will change the aging paradigm by delivering safe, quantitative early clinical diagnostics leading to preventative treatments for vascular-related cognitive impairment and mixed dementia.

collaborate with Imaginostics

Academic and Industry Collaborations

Imaginostics works closely with world-renowned experts to ensure the success of our products and to broaden the scope of the applications of our technology. We work with investigative collaborators at top academic institutions and hospitals through industry-sponsored research agreements and are open to additional strategic partners.


Contact us to find out more!